Kenvue Inc. (KVUE)
NYSE: KVUE
· Real-Time Price · USD
18.99
0.14 (0.74%)
At close: Sep 12, 2025, 3:59 PM
19.07
0.42%
After-hours: Sep 12, 2025, 07:04 PM EDT
0.74% (1D)
Bid | 18.97 |
Market Cap | 36.44B |
Revenue (ttm) | 15.14B |
Net Income (ttm) | 1.42B |
EPS (ttm) | 0.75 |
PE Ratio (ttm) | 25.32 |
Forward PE | 16.34 |
Analyst | Hold |
Ask | 19.12 |
Volume | 22,703,521 |
Avg. Volume (20D) | 21,070,945 |
Open | 18.82 |
Previous Close | 18.85 |
Day's Range | 18.77 - 19.42 |
52-Week Range | 17.14 - 25.17 |
Beta | 0.78 |
About KVUE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KVUE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KVUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Kenvue Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-9.35%
Kenvue shares are trading lower after a WSJ report...
Unlock content with
Pro Subscription
2 months ago
+2.25%
KVUE stock has given up its prior gain. Kenvue shares were trading higher after the company appointed Kirk Perry as interim CEO and announced an ongoing review of strategic alternatives.

23 hours ago · marketwatch.com
COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report saysShares of companies that make COVID vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths.